Position in ZVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$950,340
+$346,061 QoQ
Shares Held
66,272
+2.2% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 158 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ZVRA ranks #218 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ZVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $950,340 | 66,272 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $604,279 | 64,837 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,311,420 | 146,364 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,739,306 | 288,045 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,972,135 | 223,852 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $669,718 | 89,415 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $819,361 | 98,245 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $211,482 | 30,473 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $136,670 | 27,892 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $120,407 | 20,760 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $274,588 | 41,922 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $194,669 | 40,388 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $116,774 | 22,897 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $34,237 | 6,225 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,585 | 2,742 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $12,654 | 2,028 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $468 | 105 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $729,721 | 145,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $286,671 | 32,913 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $568,074 | 60,887 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $166,018 | 12,950 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||